MYGN logo

Myriad Genetics (MYGN) Cash From Operations

Annual CFO

-$110.90 M
-$4.60 M-4.33%

December 1, 2023


Summary


Performance

MYGN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMYGNcash flowmetrics:

Quarterly CFO

$700.00 K
-$1.90 M-73.08%

September 1, 2024


Summary


Performance

MYGN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMYGNcash flowmetrics:

TTM CFO

-$70.00 M
+$22.80 M+24.57%

September 1, 2024


Summary


Performance

MYGN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMYGNcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MYGN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-4.3%+103.8%+27.3%
3 y3 years-50.5%+109.6%+34.1%
5 y5 years-232.5%+136.8%-234.6%

MYGN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-696.2%at low-73.1%+101.3%-476.3%+51.7%
5 y5-year-232.5%at low-99.0%+101.2%-212.5%+51.7%
alltimeall time-158.3%at low-99.4%+101.2%-129.3%+51.7%

Myriad Genetics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$700.00 K(-73.1%)
-$70.00 M(-24.6%)
Jun 2024
-
$2.60 M(-114.0%)
-$92.80 M(-3.6%)
Mar 2024
-
-$18.60 M(-66.0%)
-$96.30 M(-13.2%)
Dec 2023
-$110.90 M(+4.3%)
-$54.70 M(+147.5%)
-$110.90 M(+74.6%)
Sep 2023
-
-$22.10 M(+2355.6%)
-$63.50 M(+43.7%)
Jun 2023
-
-$900.00 K(-97.3%)
-$44.20 M(-52.5%)
Mar 2023
-
-$33.20 M(+354.8%)
-$93.00 M(-12.5%)
Dec 2022
-$106.30 M(-671.5%)
-$7.30 M(+160.7%)
-$106.30 M(-2.0%)
Sep 2022
-
-$2.80 M(-94.4%)
-$108.50 M(-25.2%)
Jun 2022
-
-$49.70 M(+6.9%)
-$145.00 M(+45.4%)
Mar 2022
-
-$46.50 M(+389.5%)
-$99.70 M(-636.0%)
Dec 2021
$18.60 M(-125.2%)
-$9.50 M(-75.8%)
$18.60 M(-33.8%)
Sep 2021
-
-$39.30 M(+793.2%)
$28.10 M(+246.9%)
Jun 2021
-
-$4.40 M(-106.1%)
$8.10 M(-80.9%)
Mar 2021
-
$71.80 M(-221.1%)
$42.50 M(-395.1%)
Dec 2020
-$73.70 M(-221.4%)
-
-
Sep 2020
-
-$59.30 M(-297.7%)
-$14.40 M(-123.7%)
Jun 2020
$60.70 M(-27.5%)
$30.00 M(+78.6%)
$60.70 M(-2.4%)
Mar 2020
-
$16.80 M(-984.2%)
$62.20 M(+19.6%)
Dec 2019
-
-$1.90 M(-112.0%)
$52.00 M(-43.3%)
Sep 2019
-
$15.80 M(-49.8%)
$91.70 M(+9.6%)
Jun 2019
$83.70 M(-27.8%)
$31.50 M(+377.3%)
$83.70 M(-16.4%)
Mar 2019
-
$6.60 M(-82.5%)
$100.10 M(-4.7%)
Dec 2018
-
$37.80 M(+384.6%)
$105.00 M(+4.8%)
Sep 2018
-
$7.80 M(-83.7%)
$100.20 M(-13.5%)
Jun 2018
$115.90 M(+9.1%)
$47.90 M(+316.5%)
$115.90 M(+10.8%)
Mar 2018
-
$11.50 M(-65.2%)
$104.60 M(-22.1%)
Dec 2017
-
$33.00 M(+40.4%)
$134.20 M(+1.2%)
Sep 2017
-
$23.50 M(-35.8%)
$132.60 M(+24.9%)
Jun 2017
$106.20 M(-36.1%)
$36.60 M(-10.9%)
$106.20 M(-1.8%)
Mar 2017
-
$41.10 M(+30.9%)
$108.10 M(-4.3%)
Dec 2016
-
$31.40 M(-1182.8%)
$112.90 M(-15.5%)
Sep 2016
-
-$2.90 M(-107.5%)
$133.60 M(-19.7%)
Jun 2016
$166.30 M(+18.4%)
$38.50 M(-16.1%)
$166.30 M(-7.0%)
Mar 2016
-
$45.90 M(-11.9%)
$178.80 M(+9.8%)
Dec 2015
-
$52.10 M(+74.8%)
$162.80 M(-0.3%)
Sep 2015
-
$29.80 M(-41.6%)
$163.30 M(+16.2%)
Jun 2015
$140.50 M(-26.1%)
$51.00 M(+70.6%)
$140.50 M(+7.7%)
Mar 2015
-
$29.90 M(-43.2%)
$130.42 M(+16.7%)
Dec 2014
-
$52.60 M(+651.4%)
$111.77 M(+4.7%)
Sep 2014
-
$7.00 M(-82.9%)
$106.72 M(-43.9%)
Jun 2014
$190.20 M(+9.4%)
$40.92 M(+263.8%)
$190.20 M(-10.4%)
Mar 2014
-
$11.25 M(-76.3%)
$212.31 M(-11.0%)
Dec 2013
-
$47.55 M(-47.4%)
$238.46 M(+11.9%)
Sep 2013
-
$90.48 M(+43.5%)
$213.03 M(+22.5%)
Jun 2013
$173.90 M(+22.6%)
$63.03 M(+68.6%)
$173.90 M(+14.0%)
Mar 2013
-
$37.40 M(+69.1%)
$152.57 M(-2.1%)
Dec 2012
-
$22.11 M(-56.9%)
$155.92 M(-3.4%)
Sep 2012
-
$51.36 M(+23.1%)
$161.34 M(+13.8%)
Jun 2012
$141.80 M(+8.4%)
$41.70 M(+2.3%)
$141.80 M(+3.9%)
Mar 2012
-
$40.75 M(+48.0%)
$136.47 M(+10.3%)
Dec 2011
-
$27.53 M(-13.5%)
$123.76 M(-7.2%)
Sep 2011
-
$31.82 M(-12.5%)
$133.36 M(+1.9%)
Jun 2011
$130.83 M(-15.6%)
$36.37 M(+29.7%)
$130.83 M(-7.2%)
Mar 2011
-
$28.04 M(-24.5%)
$140.98 M(-9.4%)
Dec 2010
-
$37.13 M(+26.7%)
$155.60 M(-3.5%)
Sep 2010
-
$29.30 M(-37.0%)
$161.20 M(+3.9%)
DateAnnualQuarterlyTTM
Jun 2010
$155.09 M(+84.5%)
$46.52 M(+9.1%)
$155.09 M(+5.1%)
Mar 2010
-
$42.66 M(-0.2%)
$147.49 M(+30.9%)
Dec 2009
-
$42.73 M(+84.3%)
$112.71 M(+1.0%)
Sep 2009
-
$23.18 M(-40.5%)
$111.62 M(+32.8%)
Jun 2009
$84.04 M(-19.0%)
$38.93 M(+394.7%)
$84.04 M(-46.5%)
Mar 2009
-
$7.87 M(-81.1%)
$156.95 M(+2.2%)
Dec 2008
-
$41.64 M(-1046.6%)
$153.53 M(+37.0%)
Sep 2008
-
-$4.40 M(-103.9%)
$112.03 M(+8.0%)
Jun 2008
$103.74 M(-501.3%)
$111.84 M(+2416.7%)
$103.74 M(-1421.5%)
Mar 2008
-
$4.44 M(+2862.7%)
-$7.85 M(-54.4%)
Dec 2007
-
$150.00 K(-101.2%)
-$17.21 M(-29.0%)
Sep 2007
-
-$12.70 M(-5099.2%)
-$24.25 M(-6.2%)
Jun 2007
-$25.85 M(-7.8%)
$254.00 K(-105.2%)
-$25.85 M(-12.1%)
Mar 2007
-
-$4.92 M(-28.5%)
-$29.39 M(-6.3%)
Dec 2006
-
-$6.88 M(-51.9%)
-$31.36 M(-0.1%)
Sep 2006
-
-$14.30 M(+334.9%)
-$31.38 M(+12.0%)
Jun 2006
-$28.03 M(+20.3%)
-$3.29 M(-52.3%)
-$28.03 M(+20.6%)
Mar 2006
-
-$6.89 M(-0.2%)
-$23.24 M(-7.2%)
Dec 2005
-
-$6.90 M(-37.0%)
-$25.04 M(+11.4%)
Sep 2005
-
-$10.95 M(-829.5%)
-$22.48 M(-3.5%)
Jun 2005
-$23.30 M(-24.5%)
$1.50 M(-117.3%)
-$23.30 M(-25.5%)
Mar 2005
-
-$8.69 M(+100.0%)
-$31.29 M(+17.6%)
Dec 2004
-
-$4.34 M(-63.1%)
-$26.60 M(-8.2%)
Sep 2004
-
-$11.77 M(+81.6%)
-$28.98 M(-6.2%)
Jun 2004
-$30.88 M(-33.6%)
-$6.49 M(+62.3%)
-$30.88 M(+19.6%)
Mar 2004
-
-$4.00 M(-40.6%)
-$25.83 M(-34.7%)
Dec 2003
-
-$6.72 M(-50.8%)
-$39.57 M(-6.1%)
Sep 2003
-
-$13.68 M(+854.3%)
-$42.16 M(-9.4%)
Jun 2003
-$46.54 M(+185.3%)
-$1.43 M(-91.9%)
-$46.54 M(+14.1%)
Mar 2003
-
-$17.74 M(+90.5%)
-$40.79 M(+34.6%)
Dec 2002
-
-$9.31 M(-48.4%)
-$30.31 M(+23.5%)
Sep 2002
-
-$18.06 M(-518.4%)
-$24.55 M(+50.5%)
Jun 2002
-$16.31 M(+332.1%)
$4.32 M(-159.5%)
-$16.31 M(-2.9%)
Mar 2002
-
-$7.26 M(+104.3%)
-$16.79 M(+92.7%)
Dec 2001
-
-$3.55 M(-63.8%)
-$8.71 M(+4.9%)
Sep 2001
-
-$9.82 M(-356.0%)
-$8.31 M(+120.1%)
Jun 2001
-$3.78 M(-122.0%)
$3.84 M(+366.0%)
-$3.78 M(+52.8%)
Mar 2001
-
$823.30 K(-126.2%)
-$2.47 M(-10.9%)
Dec 2000
-
-$3.15 M(-40.5%)
-$2.77 M(-177.5%)
Sep 2000
-
-$5.29 M(-202.9%)
$3.57 M(-79.2%)
Jun 2000
$17.16 M(-221.7%)
$5.14 M(+885.0%)
$17.16 M(+108.8%)
Mar 2000
-
$522.00 K(-83.7%)
$8.22 M(+64.4%)
Dec 1999
-
$3.20 M(-61.4%)
$5.00 M(-484.6%)
Sep 1999
-
$8.30 M(-318.4%)
-$1.30 M(-90.8%)
Jun 1999
-$14.10 M(+101.4%)
-$3.80 M(+40.7%)
-$14.10 M(+15.6%)
Mar 1999
-
-$2.70 M(-12.9%)
-$12.20 M(0.0%)
Dec 1998
-
-$3.10 M(-31.1%)
-$12.20 M(+11.9%)
Sep 1998
-
-$4.50 M(+136.8%)
-$10.90 M(+55.7%)
Jun 1998
-$7.00 M(+6.1%)
-$1.90 M(-29.6%)
-$7.00 M(+150.0%)
Mar 1998
-
-$2.70 M(+50.0%)
-$2.80 M(-28.2%)
Dec 1997
-
-$1.80 M(+200.0%)
-$3.90 M(-30.4%)
Sep 1997
-
-$600.00 K(-126.1%)
-$5.60 M(-15.2%)
Jun 1997
-$6.60 M(-571.4%)
$2.30 M(-160.5%)
-$6.60 M(-25.8%)
Mar 1997
-
-$3.80 M(+8.6%)
-$8.90 M(+74.5%)
Dec 1996
-
-$3.50 M(+118.8%)
-$5.10 M(+218.8%)
Sep 1996
-
-$1.60 M
-$1.60 M
Jun 1996
$1.40 M
-
-

FAQ

  • What is Myriad Genetics annual cash flow from operations?
  • What is the all time high annual CFO for Myriad Genetics?
  • What is Myriad Genetics annual CFO year-on-year change?
  • What is Myriad Genetics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Myriad Genetics?
  • What is Myriad Genetics quarterly CFO year-on-year change?
  • What is Myriad Genetics TTM cash flow from operations?
  • What is the all time high TTM CFO for Myriad Genetics?
  • What is Myriad Genetics TTM CFO year-on-year change?

What is Myriad Genetics annual cash flow from operations?

The current annual CFO of MYGN is -$110.90 M

What is the all time high annual CFO for Myriad Genetics?

Myriad Genetics all-time high annual cash flow from operations is $190.20 M

What is Myriad Genetics annual CFO year-on-year change?

Over the past year, MYGN annual cash flow from operations has changed by -$4.60 M (-4.33%)

What is Myriad Genetics quarterly cash flow from operations?

The current quarterly CFO of MYGN is $700.00 K

What is the all time high quarterly CFO for Myriad Genetics?

Myriad Genetics all-time high quarterly cash flow from operations is $111.84 M

What is Myriad Genetics quarterly CFO year-on-year change?

Over the past year, MYGN quarterly cash flow from operations has changed by +$19.30 M (+103.76%)

What is Myriad Genetics TTM cash flow from operations?

The current TTM CFO of MYGN is -$70.00 M

What is the all time high TTM CFO for Myriad Genetics?

Myriad Genetics all-time high TTM cash flow from operations is $238.46 M

What is Myriad Genetics TTM CFO year-on-year change?

Over the past year, MYGN TTM cash flow from operations has changed by +$26.30 M (+27.31%)